Modulation of the discriminative stimulus effects of mu opioid agonists in rats:: I.: Effects of dopamine D2/3 antagonists

被引:6
|
作者
Cook, CD [1 ]
Beardsley, RM [1 ]
机构
[1] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
来源
BEHAVIOURAL PHARMACOLOGY | 2004年 / 15卷 / 01期
关键词
drug discrimination; heroin training dose; nafadotride; BP897; morphine; methadone; nalbuphine; rat;
D O I
10.1097/00008877-200402000-00008
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Mu opioid receptor agonists such as morphine stimulate the release of dopamine (DA) in various brain regions. These increases in DA are thought to be involved in some of the behavioral effects of mu agonists. The present study was designed to examine the modulatory actions of two D-2/3 antagonists (nafadotride and eticlopride), the D-2/3 partial agonist BP897, the D-1/2 antagonist flupenthixol, and the D, antagonist SCH23390 on the discriminative stimulus effects of the mu partial agonist nalbuphine and the higher-efficacy mu agonists heroin, methadone and morphine, in rats trained to discriminate heroin from water. Both nafadotride and eticlopride attenuated the effects of the mu agonists, whereas BP897 was effective against nalbuphine and partially effective against morphine. Flupenthixol attenuated the heroin-like discriminative stimulus effects of heroin and morphine, although not as completely as nafadotride or eticlopride. SCH23390 was least effective and produced little attenuation. These results demonstrate that the discriminative stimulus effects of mu agonists in rats are more readily attenuated by drugs that block D-2-like, rather than D-1-like, receptors.
引用
收藏
页码:65 / 74
页数:10
相关论文
共 50 条
  • [21] Involvement of dopamine D2 receptor signal transduction in the discriminative stimulus effects of the κ-opioid receptor agonist U-50,488H in rats
    Mori, Tomohisa
    Yoshizawa, Kazumi
    Ueno, Tamami
    Nishiwaki, Mizuki
    Shimizu, Norifumi
    Shibasaki, Masahiro
    Narita, Minoru
    Suzuki, Tsutomu
    BEHAVIOURAL PHARMACOLOGY, 2013, 24 (04): : 275 - 281
  • [22] POLYDIPSIA AND DOPAMINE - BEHAVIORAL-EFFECTS OF DOPAMINE D1 AND D2 RECEPTOR AGONISTS AND ANTAGONISTS
    MITTLEMAN, G
    ROSNER, AL
    SCHAUB, CL
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 271 (02): : 638 - 650
  • [23] Modulation of the discriminative-stimulus effects of cocaine by dopamine β-hydroxlyase inhibitors in rats
    Manvich, Daniel F.
    DeBrouse, Lauren
    Weinshenker, David
    FASEB JOURNAL, 2013, 27
  • [24] Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats
    Suzuki, T
    Mori, T
    Tsuji, M
    Maeda, J
    Kishimoto, Y
    Misawa, M
    Nagase, H
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 324 (01) : 21 - 29
  • [25] Effects of kappa opioid agonists on the discriminative stimulus effects of cocaine in rhesus monkeys
    Negus, SS
    Mello, NK
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 1999, 7 (04) : 307 - 317
  • [26] BEHAVIORAL-EFFECTS INDUCED IN RATS AND CHICKS BY D2 DOPAMINE AGONISTS
    FERRARI, F
    GIULIANI, D
    PHYSIOLOGY & BEHAVIOR, 1993, 54 (04) : 695 - 700
  • [27] Effects of dopamine D1- or D2-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA
    Marcy J. Bubar
    Kami M. Pack
    Paul S. Frankel
    Kathryn A. Cunningham
    Psychopharmacology, 2004, 173 : 326 - 336
  • [28] Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia:: I.: Adenosine agonists
    Dixon, DA
    Fenix, LA
    Kim, DM
    Raffa, RB
    ANNALS OF PHARMACOTHERAPY, 1999, 33 (04) : 480 - 488
  • [29] Effects of dopamine D1- or D2-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA
    Bubar, MJ
    Pack, KM
    Frankel, PS
    Cunningham, KA
    PSYCHOPHARMACOLOGY, 2004, 173 (3-4) : 326 - 336
  • [30] EFFECTS OF D1 AND D2 DOPAMINE ANTAGONISTS ON BEHAVIOR OF POLYDIPSIC RATS
    TODD, KG
    BECK, CHM
    MARTINIVERSON, MT
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1992, 42 (03) : 381 - 388